Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: Characterization of novel tachykinin receptor antagonists

FEBS Letters

Volumn 399, Issue 3, 1996, Pages 321-325

  Derocq, Jean Marie ^a   Ségui, Michel ^a   Blazy, Chantal ^a   Emonds Alt, Xavier ^a   Le Fur, Gérard ^a   Brelière, Jean Claude ^a   Casellas, Pierre ^a  

^a SANOFI   (France)

Author keywords

Astrocyte; Cytokine; Monocyte; Mononuclear cell; Substance P; Tachykinin receptor antagonist

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; NEUROKININ A; NEUROKININ B; NOLPITANTIUM; OSANETANT; SAREDUTANT; SUBSTANCE P; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; DRUG POTENCY; HUMAN; INFLAMMATION; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ASTROCYTES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MONOCYTES; PIPERIDINES; QUINUCLIDINES; RECEPTORS, NEUROKININ-1; SUBSTANCE P; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030590913     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(96)01346-4     Document Type: Article

References (36)

1. [1] Guard, S. and Watson, S.P. (1991) Neurochem. Int. 18, 149-165.
2. [2] Torrens, Y., Beaujouan, J.C., Saffroy, M., Daguet de Montety, M.C., Bergstrom L. and Glowinski J. (1986) Proc. Natl. Acad. Sci. USA 83, 9216-9220.
3. [3] Marriot, D.R., Wilkin, G.P. and Wood, J.N. (1991) J. Neurochem. 56, 259-265.
4. [4] Lee, C.M., Kum, W., Cockram, C.S., Teoh, R. and Young, J.D. (1989) Brain Res. 488, 328-331.
5. [5] Eddleston, M. and Mucke, L. (1993) Neuroscience 54, 15-36.
6. [6] Kostyk, S.K., Kowall, N.W. and Hauser, S.L. (1989) Brain Res. 504, 284-288.
7. [7] Palma, C., Urbani, F. and Manzini, S. (1995) J. Neuroimmunol. 59, 155-163.
8. [8] Emonds-Alt, X., Doutremepuich, J.D., Heaulme, M., Neliat, G., Santucci V., Steinberg, R., Vilain, P., Bichon, D., Ducoux, J.P., Proietto, V., Van Broek, D., Soubrié, P., Le Fur, G. and Brelière, J.C. (1993) Eur. J. Pharmacol. 250, 403-413.
9. [9] Emonds-Alt, X., Vilain, P., Goulaouic, P., Proietto, V., Van Broek, D., Advenier, E., Naline, G., Neliat, G., Le Fur, G. and Brelière, J.C. (1992) Life Sci. 50, PL101-PL106.
10. [10] Emonds-Alt, X., Bichon, D., Ducoux, J.P., Heaulme, M., Miloux, B., Poncelet, M., Proietto, V., Van Broek, D., Vilain, P., Neliat, G., Soubrié, P., Le Fur, G. and Brelière J.C. (1995) Life Sci. 56, PL27-PL32.
11. [11] Lotz, M., Vaughan, J.H. and Carson, D.A. (1988) Science 241, 1218-1222.
12. [12] Laurenzi, M.A., Persson, M.A.A., Dalsgaard, C.J. and Haegerstrand, A. (1990) Scand. J. Immunol. 31, 529-533.
13. [13] Nair, M.P.N. and Schwartz, S.A. (1995) Cell. Immunol. 166, 286-290.
14. [14] Gitter, B.D., Regoli, D., Howbert, J.J., Glasebrook, A.L. and Waters D.C. (1994) J. Neuroimmunol. 51, 101-108.
15. [15] Emonds-Alt, X., Doutremepuich, J.D., Jung, M., Proietto, V., Santucci, V., Van Broek, D., Vilain, P., Soubrié, P., Le Fur, G. and Brelière, J.C. (1993) Neuropeptides 24, 231.
16. [16] Oury-Donat, F., Lefevre, I.A., Thurneyssen, O., Gauthier, T., Bordey, A., Feltz, P., Emonds-Alt, X., Le Fur, G. and Soubrié, P. (1994) J. Neurochem. 62, 1399-1407.
17. [17] Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B. and Berger, M. (1991) FEBS Lett. 285, 111-114.
18. [18] Potter, H. (1992) Prog. Brain Res. 94, 447-458.
19. [19] Vandenabeele, P. and Fiers, W. (1991) Immunol. Today 12, 217-219.
20. [20] Frei, K., Malipero, V.V., Leist, T.P., Zinkernagel, R.M., Schwab, M.E. and Fontana, A. (1989) Eur. J. Immunol. 19, 689-694.
21. [21] Yankner, B.A., Caleres, A. and Duffy, L.K. (1990) Proc. Natl. Acad. Sci. USA 87, 9020-9023.
22. [22] Giulan, D. Baker, T.J., Shih, L.C. and Lachmann, L.B., (1986) J. Exp. Med. 164, 594-604.
23. [23] Payan, D.G., Brewster, D.R., Missirian-Bastian, A. and Goetzl, E.J. (1984) J. Clin. Invest. 74, 1532-1535.
24. [24] Jeurissen, F., Kavelaars, A., Korstjens, M., Broeke, D., Franklin, R.A., Gelfand, E.W. and Heijnen, C.J. (1994) J. Immunol. 152, 2987-2994.
25. [25] Kavelaars, A., Broeke, D., Jeurissen, F., Kardux, J., Meijer, A., Fanklin, R., Gelfand, E.W. and Heijnen, C.J. (1994) J. Immunol. 153, 3691-3699.
26. [26] Sargent, D.F., Bean, J.W. and Schwyzer, R. (1989) Biophys. Chem. 34, 103-110.
27. [27] Mousli, M., Bronner, C., Landry, Y., Bockaert, J. and Rouot, B. (1990) FEBS Lett. 259, 260-265.
28. [28] Bueb, J.L., Mousli, M., Bronner, C., Rouot, B. and Landry, Y. (1990) Mol. Pharmacol. 38, 816-821.
29. [29] Kavelaars, A., Jeurissen, F., Von Frijtag Drabbe Künzel, J., Van Roijen, J.H., Rijkers, T. and Heijnen, C.J. (1993) J. Neuroimmunol. 42, 61-67.
30. [30] Torrens, Y., Beaujouan, J.C., Saffroy, M., Daguet De Montety, M.C., Bergstrom, L. and Glowinski, J. (1986) Proc. Natl. Acad. Sci. USA 83, 9216-9220.
31. [31] Marriot, D.R., Wilkin, G.P. and Wood, J.N. (1991) J. Neurochem. 56, 259-265.
32. [32] Martin, F.C., Charles, A.C., Sanderson, M.J. and Merril, J.E. (1992) Brain Res. 599, 13-18.
33. [33] Luber-Narod, J., Kage, R. and Leeman, S.E. (1994) J. Immunol. 152, 819-822.
34. [34] Rogers, J. and Morrison, J.H. (1985) J. Neurosci. 5, 2801-2807.
35. [35] Carboni, A.A., Lavelle, W.G., Barnes, C.L. and Cipollini, P.B. (1990) J. Comp. Neurol. 291, 583-589.
36. [36] Iritani, S., Fujii, M. and Satoh, K. (1989) Br. Res. Bull. 22, 295-301.